Konica Minolta
Realm IDx Cancer Genome Profiling Test Gets National Health Coverage in Japan
The company said it will launch the test, which combines DNA and RNA analysis, for research use only in markets outside of Japan.
Sophia Genetics, Realm IDx Sign Letter of Intent to Expand NGS in Cancer Care
The firms expect to codevelop genomic applications based on Realm IDx subsidiary Ambry Genetics' TumorNEXT-HRD and other NGS assays.
Konica Minolta Joins Precede Consortium to Improve Diagnosis and Treatment of Pancreatic Cancer
The company will employ its Lattice platform to shepherd and translate genomic and other data toward the development of new early diagnostics and interventions.